Latest Testicular cancer Stories
By Ouellette, James R; Harboe-Schmidt, Jens Erik; Luthringer, Daniel; Brackert, Sandra; Silberman, Allan W Metastatic lesions to the testicle are uncommon. The authors report a testicular mass as the initial manifestation of distant metastasis from colorectal cancer.
Survivors of testicular cancer have a moderately increased risk of heart attack at young ages, according to Dutch researchers.
By Anne Harding NEW YORK (Reuters Health) - Men who are undergoing treatment for infertility are 20 times more likely than men in the general population to be diagnosed with testicular cancer, a new study shows.
NEW YORK (Reuters Health) - After treatment for testicular cancer, about 71 percent of men achieve fatherhood, new research indicates. However, the type of treatment has a strong impact on the paternity rate.
Men like cyclist Lance Armstrong and comedian Tom Green who survived testicular cancer are at increased risk of developing other types of cancer for at least 35 years after being diagnosed with the original disease, a new analysis shows.
By Amy Norton NEW YORK (Reuters Health) - Sperm banking may not only preserve young cancer patients' ability to have children, but their emotional well-being as well, according to Japanese researchers.
NEW YORK (Reuters Health) - Pregnant women's weight is apparently associated with the subsequent risk of testicular cancer in male offspring once they become adults, according to a Scandinavian study.
By Patrick Vignal PARIS (Reuters) - Seven-times Tour de France winner Lance Armstrong has denied ever taking performance-enhancing drugs following a report in French newspaper L'Equipe that he had used the blood-boosting drug EPO.
By Patrick Vignal PARIS (Reuters) - Seven-times Tour de France winner Lance Armstrong has denied ever taking performance-enhancing drugs following a report in French newspaper L'Equipe that he used the blood-boosting drug EPO in 1999.
NEW YORK (Reuters Health) - After surgery, a single dose of carboplatin appears to be just as effective in preventing relapse as three weeks of radiation therapy in men with early-stage testicular cancer, according to the findings of a study published in this week's issue of The Lancet.